Avanir Pharmaceuticals To Present At 24th Annual Piper Jaffray Healthcare Conference
ALISO VIEJO, Calif., Nov. 21, 2012 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced that company management will present an overview of the company at the 24th Annual Piper Jaffray Healthcare Conference in New York, NY.
- Location: Palace Hotel, New York, NY
- Presentation date: Tuesday, November 27, 2012
- Presentation time: 1:30 p.m. ET
A live webcast and 30-day archive of this presentation will be available at http://ir.avanir.com.
About Avanir Pharmaceuticals, Inc.
Avanir Pharmaceuticals, Inc. is a biopharmaceutical company focused on bringing innovative medicines to patients with central nervous system disorders of high unmet medical need. As part of our commitment, we have extensively invested in our pipeline and are dedicated to advancing medicines that can substantially improve the lives of patients and their loved ones. For more information about Avanir, please visit www.avanir.com.
AVANIR® is a trademark or registered trademark of Avanir Pharmaceuticals, Inc. in the United States and other countries.
©2012 Avanir Pharmaceuticals, Inc. All Rights Reserved.
Avanir Investor & Media Contact
Ian Clements , PhD
ir@avanir.com
+1 (949) 389-6700
SOURCE Avanir Pharmaceuticals, Inc.
RELATED LINKS
http://www.avanir.com
More by this Source
Avanir Pharmaceuticals to Participate in Two Upcoming Investor Conferences
May 22, 2013, 09:00 ET
Avanir Pharmaceuticals Reports Fiscal 2013 Second Quarter Financial and Business Results
May 08, 2013, 16:01 ET
Avanir Pharmaceuticals Announces Date of Fiscal 2013 Second Quarter Financial Results and Conference Call
May 01, 2013, 08:30 ET
Featured Video
Journalists and Bloggers
Visit PR Newswire for Journalists for releases, photos, ProfNet experts, and customized feeds just for Media.
View and download archived video content distributed by MultiVu on The Digital Center.
Custom Packages
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.